Risk of ICI-related cutaneous irAEs increased with HLA‐B*51:01 allele

Reactions Weekly 2026

View at publisher

DOI: 10.1007/s40278-026-92355-9

Cited by: 0

References: 1

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Drug-Induced Adverse Reactions Pharmacovigilance and Adverse Drug Reactions

References 1